NDAINTRAMUSCULARSOLUTION
Approved
Sep 2018
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
SEIZALAM (midazolam hydrochloride) by Medcaptain Medical Technology is short-acting benzodiazepine central nervous system (cns) depressant. Approved for atopic dermatitis. First approved in 2018.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SEIZALAM (midazolam hydrochloride) is a short-acting benzodiazepine CNS depressant administered intramuscularly as a solution. It is approved for atopic dermatitis, a chronic inflammatory skin condition affecting millions globally. The drug works by enhancing GABA-mediated inhibition in the central nervous system.
Peak
SEIZALAM is at peak lifecycle stage; teams are focused on market consolidation and defending share against a crowded competitive landscape.
Mechanism of Action
short-acting benzodiazepine central nervous system (CNS) depressant.
Clinical Trials (2)
Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting
Started Apr 2018
3 enrolled
Nervous System Diseases
Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in Japan
Started Oct 2017
25 enrolled
Nervous System Diseases
Worked on SEIZALAM at Medcaptain Medical Technology? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.